News
June 16, 2026
New insights into gene therapy for CMT1A
Researchers are making progress with therapies targeting the PMP22 gene, the cause of the most common form of CMT.
Read more
June 1, 2026
The importance of adapted exercise in CMT
Tailored physical activity helps maintain muscle strength and fitness without overloading the nerves.
Read more